Botox bunny lines: why and how are nose lines treated?
Bunny lines are small diagonal lines on the upper nose that appear when you scrunch your nose or smile broadly. Their treatment with botulinum toxin is described by expert consensus documents, but it is not in any French product label: it is an off-label use. Here is what is known.
The nose is one of the eleven areas of our atlas of areas treated with botulinum toxin. This page is about bunny lines, the small lines on the upper nose: where they come from, what is known about their treatment, why it is an off-label use in France, and which questions to ask. It does not replace a consultation.
Why are bunny lines treated?
Bunny lines are vertical and diagonal lines on the sides of the upper nose, between the inner corner of the eye and the bridge of the nose. They are attributed to the contraction of the nasalis, the muscle that scrunches the nose1. They show when you wrinkle your nose or laugh.
An anatomical study published in 2025 looked more closely at what lies beneath these lines1. In volunteers examined by ultrasound and in dissection specimens, it found a small area without muscle, surrounded by several muscles: the procerus (between the eyebrows), the nasalis, the orbicularis oculi and a muscle that lifts the side of the nose and the upper lip1. The authors conclude that injections should target the edges of these muscles rather than the line itself1.
Treatment of this area is described in expert consensus documents on botulinum toxin in aesthetics, from 2004 and 20102,3. The 2010 one was written by an expert board convened around one manufacturer’s product3. The 2010 consensus also describes treatment of a drooping nose tip3.
What the toxin does not do: it does not change the shape of the nose, does not correct a bump or a deviation, and does not act on lines caused by skin quality.
When is the toxin used?
There are no official criteria for this area, since no French label provides for it. The expert consensus documents stress individual assessment before any treatment2. In practice, the question mostly arises when these lines bother the person, at rest or in motion.
The contraindications in the labels apply whatever the area: allergy to the toxin or to a component of the product, a generalised disorder of the muscles and of the junction between nerve and muscle (myasthenia gravis, Lambert-Eaton syndrome), an infection at the injection site4,5. Treatment is not recommended during pregnancy or breastfeeding4,5.
Which toxin for bunny lines?
| Toxin | Status in France |
|---|---|
| Long-acting botulinum toxin (type A) | No aesthetic indication for this area in the SmPCs in force in France: off-label use, to be discussed with your doctor |
| Short-acting botulinum toxin (serotype E) | No aesthetic indication for this area in the SmPCs in force in France: off-label use, to be discussed with your doctor |
The type A toxins approved for aesthetic use in France cover frown lines and, depending on the product, crow’s feet and forehead lines5,6. None provides for bunny lines. The short-acting botulinum toxin (serotype E) is approved for frown lines only, in the European Union and in Canada4,7. For this area, any injection is therefore off-label, whatever the toxin. The expert consensus documents cited concern type A toxins2,3.
Is it right for me?
Your doctor will look at how your nose wrinkles, at rest and when you smile, and whether you have already had injections in neighbouring areas. They will take into account your medical history, your treatments and any pregnancy plans.
Questions to ask your doctor: is this treatment off-label, and why are you suggesting it? Where will you inject? Could my smile change? How long should the effect last, in your experience? What are the alternatives?
Onset and duration
No label gives an onset or duration for this area, and the abstracts of the consensus documents consulted provide no figure2,3. We therefore prefer not to give one. For the approved areas, type A labels describe an improvement within a few days and an effect lasting up to about 4 months5,6.
How these timelines work in general is explained on the page about how quickly botulinum toxin takes effect.
What are the risks in this area?
For any botulinum toxin injection, the labels describe injection-site reactions: pain, redness, swelling, a small bruise4. The upper nose is surrounded by muscles used for facial expression, including a muscle that lifts the upper lip1. Spread to these muscles could, in theory, change the smile. The smile and its muscles are covered on the page about the gummy smile, and the neighbouring lines at the corner of the eye on the page about crow’s feet.
Difficulty swallowing, speaking or breathing requires immediate medical attention4. A visual disturbance should also be checked by a doctor promptly. If you are not happy with the result, the page on the nose after an injection describes the most common situations.
Key points
Frequently asked questions
What are bunny lines?
They are small vertical and diagonal lines on the sides of the upper nose, which appear when you scrunch your nose or smile broadly. They are attributed to the contraction of the nasalis muscle1. The name comes from the way a rabbit wrinkles its nose. They are not the same as frown lines, which form between the eyebrows.
Is treating bunny lines with botulinum toxin approved in France?
No. No French botulinum toxin label provides for this area: the type A toxins approved for aesthetic use cover frown lines and, depending on the product, crow’s feet and the forehead5,6, and the short-acting toxin covers frown lines only4. The treatment is described by expert consensus documents2,3, but it is an off-label use.
How long does the effect last on bunny lines?
Sources
- 1.Ahn H. et al., anatomical origin of bunny lines: cadaveric dissection and ultrasound, Clinical Anatomy, 2025 (opens in a new tab) — Clinical Anatomy
- 2.Carruthers J. et al., expert consensus on botulinum toxin in facial aesthetics, Plastic and Reconstructive Surgery, 2004 (opens in a new tab) — Plastic and Reconstructive Surgery
- 3.Ascher B. et al., international consensus recommendations on type A botulinum toxin in aesthetics, part II: middle and lower face, neck and chest, Journal of the European Academy of Dermatology and Venereology, 2010 (expert board convened around one manufacturer’s product) (opens in a new tab) — Journal of the European Academy of Dermatology and Venereology
- 4.Summary of product characteristics of the serotype E botulinum toxin approved in the European Union (EPAR annex I) (opens in a new tab) — European Commission (Union Register of medicinal products)
- 5.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 68150775) (opens in a new tab) — French public medicines database (BDPM)
- 6.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 61592762) (opens in a new tab) — French public medicines database (BDPM)
- 7.Canadian product monograph of the serotype E botulinum toxin (authorization date: 2026-06-22) (opens in a new tab) — Health Canada